SYNTHESIS, PHARMACOLOGY AND USE OF NEW AND SELECTIVE FMS-LIKE TYROSINE KINASE 3 (FLT3) FLT3 INHIBITORS
作者： Pongratz Herwig , Mahboobi Siavosh , Krämer Oliver , Kindler Thomas , Pilsl Bernardette
DOI:
关键词: Small molecule 、 Myeloid leukemia 、 Fms-Like Tyrosine Kinase 3 、 Pharmacology 、 Chemistry
摘要: The present invention relates to small molecule compounds of formula (I) and their use as FLT3 inhibitors for the treatment various diseases, such acute myeloid leukemia (AML). further methods synthesizing treatment.
lens.org 参考文章(50)
Lyman, Biology of flt3 ligand and receptor. International Journal of Hematology. ,vol. 62, pp. 63- 73 ,(1995) , 10.1016/0925-5710(95)00389-A
Heiko Konig, Cedric Santos, Signal transduction in Acute Myeloid Leukemia - Implications for Novel Therapeutic Concepts. Current Cancer Drug Targets. ,vol. 15, pp. 803- 821 ,(2015) , 10.2174/1568009615666150817104916
C C Smith, K Lin, A Stecula, A Sali, N P Shah, FLT3 D835 mutations confer differential resistance to type II FLT3 inhibitors Leukemia. ,vol. 29, pp. 2390- 2392 ,(2015) , 10.1038/LEU.2015.165
Michael R. Grunwald, Mark J. Levis, FLT3 Tyrosine Kinase Inhibition as a Paradigm for Targeted Drug Development in Acute Myeloid Leukemia Seminars in Hematology. ,vol. 52, pp. 193- 199 ,(2015) , 10.1053/J.SEMINHEMATOL.2015.03.004
S Misawa, S Horiike, K Kashima, H Kaneko, T Iwai, M Nakao, S Yokota, T Fujimoto, Y Sonoda, Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia. ,vol. 10, pp. 1911- 1918 ,(1996)
Rimma Berenstein, Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory Analysis. Biomarker Insights. ,vol. 10, pp. 1- 14 ,(2015) , 10.4137/BMI.S22433
Daniel Lipka, Florian Heidel, Christoph Huber, Thomas Fischer, Entwicklung von Tyrosinkinase-Inhibitoren bei hämatologischen Neoplasien. FLT3 und JAK2 als therapeutischeTargets Pharmazie in unserer Zeit. ,vol. 37, pp. 394- 403 ,(2008) , 10.1002/PAUZ.200800280
S Yokota, H Kiyoi, M Nakao, T Iwai, S Misawa, T Okuda, Y Sonoda, T Abe, K Kahsima, Y Matsuo, T Naoe, Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines Leukemia. ,vol. 11, pp. 1605- 1609 ,(1997) , 10.1038/SJ.LEU.2400812
Allison Galanis, Hayley Ma, Trivikram Rajkhowa, Abhijit Ramachandran, Donald Small, Jorge Cortes, Mark Levis, Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants Blood. ,vol. 123, pp. 94- 100 ,(2014) , 10.1182/BLOOD-2013-10-529313
Steven Knapper, Alan K. Burnett, Tim Littlewood, W. Jonathan Kell, Sam Agrawal, Raj Chopra, Richard Clark, Mark J. Levis, Donald Small, A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy. Blood. ,vol. 108, pp. 3262- 3270 ,(2004) , 10.1182/BLOOD-2006-04-015560